Dawn C. Schwenke

Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.

T E Carew, Dawn C. Schwenke, Daniel Steinberg · Proceedings of the National Academy of Sciences · 1987 · 1K citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Structural Identification by Mass Spectrometry of Oxidized Phospholipids in Minimally Oxidized Low Density Lipoprotein That Induce Monocyte/Endothelial Interactions and Evidence for Their Presence in Vivo

Andrew D. Watson, Norbert Leitinger, Mohamad Navab et al. · Journal of Biological Chemistry · 1997 · 752 citations · Full text

Life Sciences, Biochemistry, Lipid Biochemistry +16

Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance

Ralph A. DeFronzo, Devjit Tripathy, Dawn C. Schwenke et al. · New England Journal of Medicine · 2011 · 743 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Initiation of atherosclerotic lesions in cholesterol-fed rabbits. II. Selective retention of LDL vs. selective increases in LDL permeability in susceptible sites of arteries.

Dawn C. Schwenke, T E Carew · Arteriosclerosis An Official Journal of the American Heart Association Inc · 1989 · 345 citations · Full text

Life Sciences, Cardiology, Bioavailability +14

Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentration precede development of fatty streak lesions.

Dawn C. Schwenke, T E Carew · Arteriosclerosis An Official Journal of the American Heart Association Inc · 1989 · 273 citations · Full text

Life Sciences, Biochemistry, Cardiology +15